Search

everythinglearnresearchcommunity

for

Search:↓

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Menopause-related skin changes may increase fungal infections and inflammation.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Certain genes influence immunoglobulin levels in Chinese Holstein cows, which can improve calf health.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

Researchers found four genes that could help diagnose severe alopecia areata early.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Many medications may be linked to cognitive disorders, but most lack warnings on labels.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

C4BPA protein may link acne severity and insulin resistance.

The model and estimator can predict drug exposure in kidney transplant patients well.

Erdr1 could be a new marker for diagnosing hair loss.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Low humidity changes skin gene expression, but emollients can help manage these changes.